Phytoestrogens in the Prevention of Postmenopausal Bone Loss

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Postmenopausal osteoporosis is a condition associated with low bone mass resulting from the increased bone resorption that occurs following a decline in estrogen levels. Phytoestrogens are plant-derived compounds that have affinity to the estrogen receptor and are able to act as either estrogen agonists or antagonists. Because of their structural similarity to 17-beta-estradiol, they have been studied extensively for their role in the prevention of postmenopausal bone loss. An extensive number of studies employing different types of isoflavone preparations (including soy foods, soy-enriched foods, and soy isoflavone tablets) have been conducted in a wide range of populations, including Western and Asian women. Although there is considerable variability in study design and duration, study population, type of soy isoflavone employed in the intervention, and study outcomes, the evidence points to a lack of a protective role of soy isoflavones in the prevention of postmenopausal bone loss.

Original languageEnglish (US)
Pages (from-to)445-449
Number of pages5
JournalJournal of Clinical Densitometry
Issue number4
StatePublished - Oct 2013


  • Bone health
  • Fractures
  • Menopause
  • Osteoporosis
  • Phytoestrogens

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Phytoestrogens in the Prevention of Postmenopausal Bone Loss'. Together they form a unique fingerprint.

Cite this